Skip to main content
. 2020 Nov 20;10(11):879. doi: 10.3390/brainsci10110879

Table 1.

Demographic and clinical scores (mean ± standard deviation) of the study participants.

NC (48) AD (39) MCI (104)
Age 73.4±5.7 75.4±8.8 72.8±7.4
Gender 24 M/24 F 26 M/13 F 64 M/40 F
CDR-SOB 0.04±0.13 4.8±1.3 1.41±0.7
Adas-Cog 13 9±4.7 30.9±8.7 15.9±6.7
MMSE 29±1.1 23±1.8 27±1.6
MoCA 25.6±2.1 17.5±4.3 22.9±2.7
FAQ 0.23±0.92 15.1±6.9 2.7±4
RAVLT-immed 44.3±10.4 21.3±6.7 34.1±9.6
RAVLT-learn 5.12±2.3 2±1.9 4.3±2.1
RAVLT-percforg 36.2±28.2 89±19.4 56.8±32
ECog-PT-total 1.2±0.2 1.9±0.6 1.8±0.5
ECog-SP-total 1.2±0.3 2.8±0.5 1.7±0.6

(CDR-SOB, Clinical Dementia Rating Scale Sum of Boxes; ADAS-Cog-13, Cognitive subscale 13; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; FAQ, Functional Activities Questionnaire; RAVLT-immed, Rey Auditory Verbal Learning Test-immediate; RAVLT-learn, Rey Auditory Verbal Learning Test-learning; RAVLT-percforg, Rey Auditory Verbal Learning Test-percent forgetting; ECog-PT-total, Everyday Cognition participant; ECog-SP-total, Everyday Cognition Study Partner). The subjects were grouped into 48 normal controls (NC), 39 Alzheimer’s disease (AD) patients and 104 Mild Cognitive Impairment (MCI) subjects. The database consisted of 114 males (M) and 77 females (F).